Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Angiocentric glioma (AG) is an extremely rare slow-growing glial neoplasm of the central nervous system, usually arising in a superficial location in the cerebrum, affecting all ages and both sexes, and characterized by intractable seizures and headaches, with most cases being cured by surgical incision alone and therefore having a good prognosis.
Biomarker and diagnostic research for angiocentric glioma has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE4. Research is primarily industry-sponsored.
21 publications have been identified in PubMed for angiocentric glioma. Research spans Review / Meta-Analysis (35%), Case Report / Case Series (35%), and Diagnostic / Biomarker (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 7 | 35% |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 1:48 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies |
7 |
35% |
Testing and diagnosis research | 2 | 10% |
Clinical study results | 2 | 10% |
Laboratory research | 2 | 10% |
Liu T (2026). [PMID: 42136297](https://pubmed.ncbi.nlm.nih.gov/42136297/). *CNS Neurol Disord Drug Targets*. [Case Report / Case Series]
Pelissier L (2026). [PMID: 41591436](https://pubmed.ncbi.nlm.nih.gov/41591436/). *Pediatric radiology*. [Review / Meta-Analysis]
Powers AM (2026). [PMID: 41274768](https://pubmed.ncbi.nlm.nih.gov/41274768/). *Neuroimaging clinics of North America*. [Review / Meta-Analysis]
Daoud L (2025). [PMID: 40478503](https://pubmed.ncbi.nlm.nih.gov/40478503/). *Acta neurologica Belgica*. [Case Report / Case Series]
Satomi K (2025). [PMID: 39569742](https://pubmed.ncbi.nlm.nih.gov/39569742/). *Neuropathology : official journal of the Japanese Society of Neuropathology*. [Clinical Trial Publication]
Zuo P (2025). [PMID: 41288759](https://pubmed.ncbi.nlm.nih.gov/41288759/). *Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery*. [Case Report / Case Series]
Aboubakr O (2025). [PMID: 40702569](https://pubmed.ncbi.nlm.nih.gov/40702569/). *Acta neuropathologica communications*. [Case Report / Case Series]
Coppola F (2025). [PMID: 40555469](https://pubmed.ncbi.nlm.nih.gov/40555469/). *AJNR. American journal of neuroradiology*. [Basic Science / Preclinical]
Kotch C (2025). [PMID: 41198334](https://pubmed.ncbi.nlm.nih.gov/41198334/). *Advances in cancer research*. [Review / Meta-Analysis]
Peña Pino I (2025). [PMID: 41260607](https://pubmed.ncbi.nlm.nih.gov/41260607/). *Neuropathology : official journal of the Japanese Society of Neuropathology*. [Review / Meta-Analysis]